Related Experiment Video

Updated: Jul 13, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
10:03

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery

Published on: November 5, 2019

Meningitis epidemics in Africa: a brief overview

Rémy Teyssou1, Erwan Muros-Le Rouzic

  • 1Louis Malardé Institute, BP30, 98718 Papeete, Tahiti, French Polynesia. remy.teyssou@ilm.pf

Vaccine
|July 24, 2007
PubMed

Insights

Meningococcal meningitis epidemics in Africa are driven by bacterial evolution. Enhanced surveillance and molecular epidemiology are crucial for monitoring Neisseria meningitidis strains and developing effective vaccines.

Area of Science:

  • Microbiology
  • Epidemiology
  • Public Health

Background:

  • Meningococcal meningitis causes significant mortality in sub-Saharan Africa's meningitis belt.
  • Epidemic waves occur every 5-12 years, linked to bacterial antigen expression changes.
  • Serogroup A is the primary cause of death, though serogroup W135 emerged in 2002.

Purpose of the Study:

  • To analyze the molecular evolution of Neisseria meningitidis strains in Africa.
  • To inform the development of conjugate vaccines against serogroup A.
  • To highlight the importance of enhanced surveillance systems.

Main Methods:

  • Molecular epidemiology to track bacterial evolution.
  • Surveillance data analysis to monitor strain incidence.
  • Antigenic characterization of Neisseria meningitidis.

Main Results:

  • Serogroup W135 incidence decreased after 2002, with serogroup A re-emerging as dominant.
  • A new serogroup A strain (ST-2859) shows potential for future epidemics.
  • Molecular changes in meningococci facilitate spread in susceptible populations.

Conclusions:

  • Strengthening surveillance and incorporating molecular epidemiology are vital for monitoring meningococcal evolution in Africa.
  • Continuous monitoring is essential for the success of conjugate vaccine strategies.
  • Understanding bacterial evolution is key to controlling meningococcal meningitis outbreaks.

More Related Videos

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging09:04

In Vivo Tracking of Edema Development and Microvascular Pathology in a Model of Experimental Cerebral Malaria Using Magnetic Resonance Imaging

Published on: June 8, 2017

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...